The WHO 2010 Classification, incorporating both the mitotic rate and the Ki-67 index, divides NENs into low-grade (G1) neuroendocrine tumor (NET), intermediate-grade (G2) NET, and high-grade (G3) neuroendocrine carcinoma (NEC). Here, MKI67 is linked to neuroendocrine neoplasm.